An Open-label, Rollover Study Providing Continued Dosing of Gevokizumab in Order to Assess Long-term Gevokizumab Safety Data
Clinical trial NCT02258854 · TERMINATED
Trial details
- NCT number
- NCT02258854
- Sponsor
- XOMA (US) LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2017-10-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.